PEP-THERAPY
PEP-Therapy is a biotechnology company developing first-in-class peptides as targeted therapies for severe diseases, with an initial focus on cancer. PEP-Therapy develops Cell Penetrating and Interfering Peptides (CP&IP) for the intracellular delivery of targeted therapies. These active compounds penetrate cells and block relevant intracellular protein-protein interactions, thus inhibiting key pathological mechanisms.
PEP-THERAPY
Industry:
Biotechnology Medical Therapeutics
Founded:
2014-01-02
Address:
Évry, Ile-de-France, France
Country:
France
Website Url:
http://www.pep-therapy.com
Total Employee:
1+
Status:
Active
Contact:
+33 1 53 10 05 48
Total Funding:
7.85 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Global Site Tag Mobile Non Scaleable Content
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Current Advisors List
Board_member
2015-03-01
Current Employees Featured
Antoine Prestat CEO & Founder @ PEP-Therapy
CEO & Founder
2013-12-01
Founder
Investors List
i&i Prague
i&i Prague investment in Series A - PEP-Therapy
Bpifrance
Bpifrance investment in Debt Financing - PEP-Therapy
Business Angels des Grandes Ecoles
Business Angels des Grandes Ecoles investment in Series A - PEP-Therapy
Anaxago
Anaxago investment in Series A - PEP-Therapy
Business Angels des Grandes Ecoles
Business Angels des Grandes Ecoles investment in Series A - PEP-Therapy
Doorway Capital
Doorway Capital investment in Series A - PEP-Therapy
Italian Angels for Growth
Italian Angels for Growth investment in Series A - PEP-Therapy
Bernard Majoie
Bernard Majoie investment in Series A - PEP-Therapy
Magna Capital Partners
Magna Capital Partners investment in Series A - PEP-Therapy
Seventure Partners
Seventure Partners investment in Series A - PEP-Therapy
Official Site Inspections
http://www.pep-therapy.com Semrush global rank: 5.94 M Semrush visits lastest month: 1.39 K
- Host name: webacc13.sd6.ghst.net
- IP address: 155.133.142.15
- Location: Poland
- Latitude: 52.2394
- Longitude: 21.0362
- Timezone: Europe/Warsaw
More informations about "PEP-Therapy"
PEP-Therapy - Crunchbase Company Profile & Funding
PEP-Therapy is a biotechnology company developing first-in-class peptides as targeted therapies for severe diseases, with an initial focus on cancer. ... Collaboration and partnership …See details»
PEP-Therapy - Org Chart, Teams, Culture & Jobs - The …
PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology based on the Company’s innovative Cell-Penetrating and Interfering Peptides (CP&IP) technology. Industries. …See details»
Discover the PEP-Therapy management team
Prior to joining PEP-Therapy in 2014, Jennifer worked as a Consultant within the innovation financing division of a consulting firm, and then served as a Project Manager in a nanotech …See details»
A clinical-stage biotechnology company - PEP-Therapy
PEP-010, PEP-Therapy’s lead drug candidate, is a pro-apoptotic agent which has shown anti-cancer efficacy and a good safety profile. PEP-010 is currently evaluated in a Phase Ia/b …See details»
PEP-Therapy Company Profile 2024: Valuation, Funding
PEP-Therapy General Information Description. Developer of peptides designed to offer targeted therapies for severe diseases, with an initial focus on oncology. The company's peptides are …See details»
Leadership Team - Team at PEP-Therapy - The Org
The PEP-Therapy leadership team has experience in project management, finance, research, and engineering. They have been educated at some of the top universities in France including …See details»
PEP-Therapy - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... PEP-Therapy . 2: obfuscated. …See details»
PEP-Therapy Company Profile - Office Locations, Competitors
PEP-Therapy has 5 employees across 2 locations and $3 m in total funding,. See insights on PEP-Therapy including office locations, competitors, revenue, financials, executives, …See details»
PEP-Therapy - Contacts, Employees, Board Members, Advisors
Edit Board Member and Advisor Profiles Section. Number of Board Member and Advisor Profiles 1. PEP-Therapy has 1 board member or advisor, Philippe Tramoy.See details»
PEP International – Multilingual Psychotherapy
PEP International’s cooperation with the Institute for Clinical Psychology at the Leiden University ensures that our psychologists are always aware of the latest findings in the field. ... providing the same high standard therapy of the …See details»
Physician Attitudes Towards Pharmacist-Prescribed HIV Post
5 days ago PEP is a 28-day course antiretroviral therapy that must be initiated with 72 h (ideally 24 h) after a potential or known exposure to HIV to prevent subsequent infection. Prompt …See details»
Positive Expiratory Pressure (PEP) Devices - Physiopedia
One of the most frequently prescribed airway clearance therapy (ACT) options for patients with chronic lung conditions or decreased lung volumes are positive expiratory pressure therapy …See details»
PEP Therapy: Enhancing Respiratory Health and Function
Oct 1, 2024 PEP therapy has shown particular promise in managing chronic respiratory conditions like COPD, cystic fibrosis, and bronchiectasis. For people with these conditions, …See details»
PEP Seniors Therapeutic Centre - CanadaHelps
PEP is a program of care, direction and therapy which focuses on helping older Ontarians to stay healthy and stay at home longer. At PEP, we endeavour to enable our ageing population to …See details»
PEP-Therapy : entreprise innovante de biotechnologie médicale
PEP-010, le principal candidat médicament de PEP-Therapy, est un agent pro-apoptotique qui a montré une efficacité anti-tumorale dans des modèles précliniques, ainsi qu’un bon profil de …See details»
In: Proceedings of the American Association for Cancer Research …
Apr 4, 2023 in apoptosis. PEP-CIO, a drug candidate developed by PEP-Therapy, a French Biotech company, is a proapoptotic peptide targeting and disrupting this interaction leading to …See details»
Recovery is a Family Journey | PEP Society
PEP Edmonton offers support, education, and hope with professionally-facilitated innovative programming and support-line days, evenings, and weekends. Days/Evenings/Weekends - …See details»
Follow PEP-Therapy news and event (videos, articles...)
Oct 22, 2024 PEP-Therapy extends Series-A financing, raising a total of €5.4 million to progress the clinical development of its lead candidate, PEP-010. ... PEP-Therapy announces the …See details»
PEP- an additional technique for trauma therapy - dis-sos
Apr 23, 2021 PEP stands for Process- and Embodiment-focused Psychology. Like EFT it is rooted in Energy Psychology but it has moved away from these roots considerably and rejects …See details»
PEP-Therapy announces the appointments of four key opinion …
PEP-Therapy has developed a Cell Penetrating and Interfering Peptide technology (CP&IP) for the development of its therapeutic products. These innovative molecules penetrate cells and …See details»